Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population
Conclusions: RFPDT with anti-VEGF is safe and effective treatment with polyp regression and vision improvement in 80% of cases, without any complication of subretinal hemorrhage/vitreous hemorrhage.
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Parveen Sen Muna Bhende Ramya Sachidanandam Nishat Bansal Tarun Sharma Source Type: research
More News: Avastin | Eyes | Lucentis | Opthalmology | Polyps | Ranibizumab Injection | Statistics | Study